AUTOLUS THERAPEUTICS PLC REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 8th, 2024 • Autolus Therapeutics PLC • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 8th, 2024 Company Industry JurisdictionThis REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of February 6, 2024 by and between Autolus Therapeutics plc, a public limited company incorporated under the laws of England and Wales (the “Company”), and BioNTech SE, a Societas Europaea organized and existing under the laws of Germany (“Investor” and together with any additional Investor who becomes party to this Agreement the “Investors”). Capitalized terms used herein have the respective meanings ascribed thereto in the Purchase Agreement unless otherwise defined herein.
Registration Rights AgreementRegistration Rights Agreement • February 8th, 2021 • Silence Therapeutics PLC • Pharmaceutical preparations • New York
Contract Type FiledFebruary 8th, 2021 Company Industry JurisdictionThis REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of February 4, 2021 by and among Silence Therapeutics plc, a public limited company incorporated under the laws of England and Wales (the “Company”), and the “Investors” named in that certain Securities Purchase Agreement by and among the Company and the Investors, dated as of February 4, 2021 (the “Purchase Agreement”). Capitalized terms used herein have the respective meanings ascribed thereto in the Purchase Agreement unless otherwise defined herein.